Zeleciment rostudirsen (z-rostudirsen)

Name: Zeleciment rostudirsen (z-rostudirsen) in Duchenne muscular dystrophy: Corticosteroids
Published: 2026-09-14T15:39:06-04:00

Duchenne muscular dystrophy

Also known as DYNE-251

Manufacturer: Dyne Therapeutics
Regulatory submission: BLA submitted May 2026
Launch: Anticipated in the first quarter of 2027
Last updated: September 19, 2026

Section

Product information and disease description Place of product in therapy Approaches to treatment Current treatment options and standard of care

Corticosteroids

2 evidence topics · 2 sources

Corticosteroids

“Steroids remain the current gold standard for Duchenne treatment.” (opens the source at this quote in a new tab)

Daily corticosteroid regimens

“At treatment initiation (between 4-6 years), the recommended regimen is daily (prednisolone, deflazacort or vamorolone).” (opens the source at this quote in a new tab)